HepAssis2® bioartificial liver system in treating acute‐on‐chronic liver failure patients: Findings from a phase 1 randomised, open‐label clinical trial

ABSTRACT:

SUBMITTER: Zhong Z 

PROVIDER: S-EPMC12914335 | biostudies-literature | 2026 Feb

REPOSITORIES: biostudies-literature